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Chapter 4

Regulation of Genetically Engineered
Microorganisms Under FIFRA,
FFDCA and TSCA
Chris A. Wozniak, Gwendolyn McClung, Joel Gagliardi,
Mark Segal, and Keith Matthews

Abstract Since the dawn of civilization, humans have utilized microbial organisms
of various sorts for food and agricultural production. More recently, microbes have
been used for pesticidal, and environmental management purposes. With the advent
of the development of recombinant DNA technology to genetically alter microbes,
it became necessary for Federal regulators to assess the appropriate level, format, and
application of their regulatory authorities. In 1986, the Office of Science and Technology
Policy issued the Coordinated Framework for Regulation of Biotechnology. The
Coordinated Framework constituted a comprehensive regulatory policy for biotechnology that, in essence, concluded that no new statutory authorities were necessary
to effectuate a robust and efficient regulatory program for the products of biotechnology.
The Framework articulated a division of regulatory responsibilities for the various
agencies then involved with agricultural, food, and pesticidal products. Thus, in
accordance with the Framework, USDA APHIS regulates microbes that are plant
pests under the Plant Protection Act (PPA) and the National Environmental Policy
Act (NEPA); the U.S. Environmental Protection Agency (U.S. EPA) regulates
microorganisms and other genetically engineered constructs intended for pesticidal
purposes and subject to the Federal Insecticide Fungicide and Rodenticide Act
(FIFRA) and the Federal Food Drug and Cosmetic Act (FFDCA). The U.S. EPA
also regulates certain genetically engineered microorganisms used as biofertilizers,
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bioremediation agents, and for the production of various industrial compounds
including biofuels under the Toxic Substances Control Act (TSCA). The focus of
this chapter is the regulatory process for approval of the use of genetically engineered microbes under the oversight of the U.S. EPA. We will also consider instances
where organisms may be exempted from oversight and the outlook for the application of GE microbes in the future. This chapter does not seek to serve as a guidebook for navigating the details of the regulatory process, but rather as an overview
of key considerations in risk assessment and risk management.
Keywords Algae • Bacteria • Baculovirus • Biofertilizer • Biofuel • Biopesticide •
FFDCA • FIFRA • Fungi • Genetically engineered • Microorganism • MPCA • Plant
pest • Plant protection act • Regulation • TSCA

Disclaimer
The content of this chapter reflects the opinions of the authors and this chapter is not
intended to constitute a statement of the official policy or actions of the U.S.
Environmental Protection Agency.

4.1
4.1.1

Introduction
Historical Regulatory Perspective

The regulation of products of biotechnology has a lengthy history in the United
States. Prior to the development of a formal regulatory structure, many protracted
discussions took place for well over a decade among scientists, government regulators,
environmental activists, and representatives of industry (Berg and Singer 1995;
Barinaga 2000). These discussions eventually resulted in the announcement by the
Office of Science and Technology Policy (OSTP) of the Coordinated Framework
for Regulation of Biotechnology (OSTP 1986).
In February 1975, the Asilomar Conference was convened with 140 scientists,
lawyers, physicians, ethicists and other interested parties in Monterey, CA for a
comprehensive discussion of the issues surrounding the release of genetically engineered organisms into the environment. A growing sense of concern was mounting
among scientists regarding this new ability to reshuffle DNA between microbial
agents and this was a major impetus for the conference. While a formal regulatory
system would have to wait for further executive and legislative decisions, the
Congress at Asilomar helped focus the publication of the National Institutes of
Health (NIH) Recombinant DNA Guidelines in 1976 (NIH 1976), even though this
project was already underway (Marchant 1988). The primary utility of the ‘NIH
Guidelines’, as they came to be known, related to confined applications, e.g., laboratory
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work for research purposes. Recognizing, however, that the NIH Guidelines did not
provide genuine oversight for actual environmental releases of GE microbes, Federal
regulatory agencies were considering appropriate means of adequately regulating
such releases. (It should be noted that the NIH Guidelines are still in effect, with
some modifications over the years, for their original intended purpose; NIH 2011).
The principal tenet of the Coordinated Framework was that existing statutes were
sufficient to effectuate proper regulation of the products of agricultural biotechnology,
i.e., that it was not necessary to legislatively create new statutory authorities
specifically for the governance of products in the research pipeline and those that
where then envisioned. Existing statutes were considered as a sound basis for oversight
of biotechnology with modifications offered through promulgation of regulations
via rulemaking.
Given the plethora of potential products to be derived from rDNA technology,
the U.S. government was faced with the application of statutes already in use for
regulation of pesticides (i.e., FIFRA), plant pests (i.e., Plant Pest Act) and pesticide
residues on food and feed commodities (i.e., Federal Food Drug and Cosmetic Act)
with implications for the associated agencies, EPA, USDA-APHIS, HHS-FDA,
respectively. There were, of course, dissenting views as to whether relying on existing
statutes was either sufficient or preferable with regard to necessary regulatory
authorities applicable to these technologies and resulting products (Jones 1999).
Environmental releases of genetically modified organisms were proposed for the
first time nearly simultaneously by Monsanto and Advanced Genetic Sciences, Inc.
(AGS) (Watrud et al. 1985; Lindow 1985). AGS developed a product named FrostBan®,
a Pseudomonas syringae engineered such that a gene coding for a protein necessary
for ice-nucleation had been deleted, and conducted a field release on strawberry fields
in University of California experimental plots under EPA and California Department
of Food and Agriculture authority on April 24, 1987 (Smith 1997).
Initial approval granted by the NIH administrator (48FR9436; 48FR:24548) for
this field test was overturned due to a May 16, 1984 decision (OTA 1988) that the
environmental impacts under NEPA were not assessed, though the decision also
affirmed that field testing could take place once an environmental effects assessment was performed (Pizzuli 1984). Through a series of events EPA was assigned
the task of assessing environmental impacts, though the permit was withdrawn
just prior to the 1987 field test when another test, this one an experimental rooftop
injection of Frostban® into trees, was declared in violation of the issued permit
resulting in a $20,000 fine – though AGS claimed the bacterium injected into trees
was a contained use (New Scientist 1986). A field test of Frostban® on strawberry
plants did occur at Conta Costa, CA following Federal and State approvals (Supkoff
et al. 1988). Steve Lindow of the University of California at Berkeley also conducted
frost prevention tests with his deletion mutant IceMinus Ps. syringae on potato
plants at Tulelake, CA despite some vandalism by opponents of GE technology and
a lengthy permitting process (Maugh 1987).
A subsequent genetically engineered construct involved transformation systems
directing placement of Bacillus thuringiensis (B.t.) transgenic sequences into the
bacterial chromosomes of Clavibacter xyli ssp. cynodontis and Pseudomonas
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fluorescens, respectively. A system devised by Crop Genetics International (CGI)
focused on delivery of the B.t. Cry1Ac d-endotoxin in tissues of maize by introducing
genetically modified C. xyli into maize xylem vessels (Turner et al. 1991). C. xyli is
a natural endophyte of Bermuda grass, maize and several other plants, hence, its
potential as a delivery agent of a biopesticidal protein was sought as a means of
reducing feeding damage to corn earworm and European corn borers and as a way
to reduce environmental exposure to non-target organisms (Lampel et al. 1994).
Due in part to the overall concentration of the B.t. d-endotoxin contained in the
endophytic populations of C. xyli in maize, this construct ultimately failed to consistently deliver sufficient control during field trials. In addition, there were serious
concerns about the possible uncontrolled spread of the genetically engineered
microorganism to other plants. Yield was also affected in some maize varieties
because of occlusion of xylem vessels with bacteria, particularly when drought
stress was an issue (John Turner, personal communication 2011). Regulatory costs
associated with field release permits (USDA-APHIS) and experimental use permits
(US EPA) were a factor for CGI in that they were a relatively small company without
a broad portfolio of products. In 1994, further research into this mechanism of delivery
into maize was halted by CGI (Wrubel et al. 1997).
Monsanto’s approach was to create an insecticidal, plant rhizosphere dwelling
microbe by cloning the Bacillus thuringiensis subsp. kurstaki HD-1 crystalline
protein gene into strains of Pseudomonas fluorescens (Obukowicz et al. 1986).
Limited field releases of these live microorganisms occurred, though only with
strain variants engineered with reporter genes (Kleupfel et al. 1991; Angle et al.
1995; Gagliardi et al. 2001). EPA questioned the safety of pseudomonads expressing
B.t. endotoxins in aquatic environments, and this led to Monsanto’s decision to cease
work on use of engineered microbes as pesticides. Subsequent work in contained
settings has shown that runoff from simulated agricultural plots containing
Pseudomonas chlororaphis (aureofaciens) 3732 can be significant (Gillespie et al.
1995), and the general lack of available non-target aquatic invertebrate tests to evaluate
such effects leaves regulatory certainty for this use in limbo.
Subsequently, between 1991 and 1996, four genetically engineered microbial preparations were registered under FIFRA as encapsulated B. thuringiensis d-endotoxins
in killed Pseudomonas fluorescens. Delivery of the B.t. d-endotoxin in killed
Pseudomonas had a distinct advantage over using live B. thuringiensis in that higher
levels of toxins are produced by the pseudomonads during fermentations and some
protection against UV light inactivation of the toxin was gained via encapsulation
within the killed pseudomonad cell wall (OTA 1995; Mycogen 1998; Shand 1989).
Additionally, the use of killed bacteria as the end product alleviates any concerns
over spread and reproduction of the engineered pseudomonad; this was a consideration by both the company and EPA risk assessors (BLR 1988).
In addition to the transgeneric expression of B.t. d-endotoxin genes in the heatkilled pseudomonads, creating a so called ‘killed microbial’ pesticide, several companies moved forward with engineering of B. thuringiensis strains directly, either
modifying native cry gene sequences or adding to the resident cry genes with additional
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cry genes in order to broaden the range of susceptible insect species (Baum et al. 1996;
Sanahuja et al. 2011).
In addition to these pseudomonad constructs, six submissions were received by
EPA for field testing of genetically modified baculoviruses from May 1995 through
August of 1998. Four of these utilized the Autographa californica nuclear polyhedrosis virus (AcMNPV) with additions of insect-specific toxin genes: three from
two different scorpions (Summers 2006) and one from a mite (Tomalski et al. 1989).
Two others are based upon modified Helicoverpa zea single-embedded nuclear
polyhedrosis virus (HzSNPV) each using an insect-specific scorpion toxin from one
of two scorpion species. Since the main issues are very similar between the various
baculovirus constructs, only a few examples will be discussed in detail herein.
Work with engineered baculoviruses was quite active in the 1990s (Hughes et al.
1997), and even earlier in the UK (Bishop 1988) for control of insect pests on
vegetables, ornamentals, and in forestry situations, and some of this work continues
today (Tang et al. 2011). Much of the effort centered on addition of scorpion toxin
genes to enhance the kill rate of AcMNPV and HzNPV without a consequent change
in host range. Toxins from both Leiurus quinquestriatus hebraeus (Israeili yellow
scorpion; LqhIT2) and Androctonus australis hector (Algerian scorpion; AaIT)
were used by American Cyanamid and DuPont in an attempt to increase mortality
in the target pest without altering the risk profile for non-target species that may
feed on the infected insect pests (Bill Schneider, Personal Communication 2010;
Gard et al. 2002; Heinz et al. 1995; American Cyanamid 1994, 1996; DuPont 1996;
Kunimi et al. 1996).
These scorpion toxins act through either a depressant (LqhIT2) or stimulant
(AaIT) capacity on neurons through sodium channel modulation, however, they do
not have demonstrable vertebrate activity nor do they affect Crustacea (Hoover et al.
1996; Gard et al. 2002). EPA required testing of a range of surrogate species, including rats, Bobwhite quail, Mallard ducks, rainbow trout, and grass shrimp, which
were fed infected H. zea larvae. Additional tests with NPV occlusion bodies (OBs)
suspended in aqueous media indicated a lack of pathogenic or toxic effect on
Daphnia magna, the water flea. Testing of human cell lines (liver, lung, intestine)
was also performed with budding virus particles with no indication of alterations to
cell morphology or timing of division. It is noteworthy that although guidance on
assessing human health and environmental risks has adapted to newer technologies
as they arose, many of the principals have been in place prior to the advent of biotechnology and rDNA methods (Engler 1974).
Additionally, the ecdysteroid UDP-glucosyl transferase gene (egt) had been
found to alter ecdysoid hormone levels and influence killing rate, feeding period
and molting of several insect species (O’Reilly and Miller 1989, 1991; Slavicek
et al. 1999). Removal of the egt gene from the AcMNPV genome resulted in feeding
cessation and wandering behavior of infected larvae, which succumbed to the viral
infection prior to pupation. The combination of the AcMNPV/LqhIT2 toxin and
deletion of egt resulted in a higher mortality rate during initial measurements soon
after infection experiments comparing recombinant strains to wild type AcMNPV,
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however, following extended incubation (e.g. a few days post infection to as many
as 21 days depending on the virus:insect combination), mortality was equal between
the two groups. The titer of occlusion bodies present in the AcMNPV/LqhIT2 strain
was, however, significantly less than wild type infections (Tomalski and Miller
1991; Cory et al. 1994). Depending on the strain of virus and the intended host,
reductions in yield of virus have varied from 30 to 50% and the rate of kill
increased by as much as 95% (Cory 2000). The decreased viral load following
infection and the limited host range of most baculoviruses fit prominently into the
EPA’s risk assessment for these modified biopesticides. The inability of these genetically engineered baculoviruses to persist in the environment and potentially
exchange genes with wild type strains or related viruses reduced the uncertainty
associated with field release of constructs previously evaluated in laboratory settings
(OSTP 2001).
Another consideration of the risk assessment for AcMNPV/LqhIT2 and other
recombinant baculoviruses was whether these novel strains could outcompete and
eliminate wild type viruses over time. In addition to the noted decrease in viral load
following host mortality, experiments and observations demonstrated that larvae
infected with AcMNPV expressing insect-specific toxins were susceptible to
‘knockoff’ wherein they would drop from plant surfaces hours earlier than wild type
infected larvae, thereby limiting spread of the OBs onto leaf surfaces where they
may contact other larvae (Inceoglu et al. 2006). Further experiments with combinations
of GE and wild-type NPVs also indicated that sequential passage to larval hosts
resulted in the eventual elimination of the toxin expressing virus strains. In some
instances, the GE baculoviruses were comparable in efficacy to conventional
insecticides with a 30–40% increase in the speed of killing larvae as compared to
non-GE baculoviruses (Hoover et al. 1996).
Shortly after the initial proposed field releases, non-pesticidal uses of genetically
modified microorganisms began to be developed. By 1987 initial releases of Ensifer
(Rhizobium) meliloti were under TSCA review and initial experimental releases took
place by 1988 (EPA 1999). The Monsanto Pseudomonas chlororaphis (aureofaciens)
strain containing reporter genes was also submitted for TSCA review in 1987 and
went to the field that same year.
While this chapter considers the oversight of GE microorganisms by the US
EPA, it should be noted that some of these organisms may also be regulated by
the U.S. Department of Agriculture, Animal and Plant Health Inspection Service
(USDA-APHIS). Both the Plant Protection and Quarantine (PPQ) and the
Biotechnology Regulatory Services (BRS) divisions within USDA-APHIS may be
involved in the importation, movement and field release of non-GE and GE microorganisms under the Plant Protection Act and National Environmental Policy Act
(OSTP 2001). The Food and Drug Administration reviews all genetically engineered
microorganisms that may cause an alteration in the nutritional state of a food, or
otherwise contribute to a food safety issue. When in doubt as to which agencies may
exercise regulatory authority over a particular microbe and its intended use, it is best
to contact the agency directly for clarification.
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FIFRA Risk Assessment of Genetically Engineered
Microbial Pest Control Agents

Under FIFRA, microbial biopesticide products, as with all other pesticides, must be
evaluated for their risks and benefits. Bacteria, viruses, protozoa, algae, and fungi
intended for use as pesticides are regulated under FIFRA by the US EPA (40 CFR Part
158.2100). Additionally, the Agency evaluates the potential for effects upon threatened
and endangered species under the Endangered Species Act, but this will not be discussed
further in this section. There are three principal sections to the FIFRA risk assessment
for genetically engineered microbial pest control agents (GE-MPCA): product analysis,
human health, and environmental considerations (McLintock et al. 2000). The aim of
this chapter is not to consider the data requirements associated with these sections in
great detail, but, rather, to present an overview of key considerations. One important
note: EPA evaluates an MPCA using the same data requirements, regardless of whether
it is genetically engineered or naturally occurring (Baum 1998).
Under the product characterization section (40 CFR Part 158.2120) of the data requirements a summary of the taxonomy, natural history, target, and non-target host range is
required. For any genetically modified MPCA, the product analysis portion of the data
requirements seeks to provide the risk assessor with necessary information regarding the
nature of the transformation event and includes DNA sequences of transgenes, associated
vector sequences with restriction map, DNA source information and an indication of
transgene stability over multiple generations or growth cycles (e.g., 5 batch analysis).
Also critical to this section is the Confidential Statement of Formula, which details the
active ingredient(s), inert ingredients, and concentration of the MPCA in its final product
formulation. Any pesticide in use under a FIFRA Section 5 Experimental Use Permit, or
Section 3 Registration, which is not in accord with the information present on the CSF is
considered as ‘Misbranded’ and therefore illegal (FIFRA 2(q)).
Toxicology data requirements (40 CFR, Part 158.2140) explore the potential
impact of the MPCA on humans in terms of toxicity, infectivity and pathogenicity.
The MPCA is introduced via oral, pulmonary, and injection (intravenous or
intraperitoneal) routes into rodent test animals functioning as surrogates. Animal
body and organ weights, behavior, and mortality are all assessed as part of these
studies, but most important is establishing clearance of the MPCA from the body
over time. These high dose tests (at least 108 units of the MPCA per test animal) are
intended to examine the outcomes following a single, significant contact with an
MPCA by various exposure routes (mouth, nose, lungs, and dermal).
Non-target organism and environmental fate data requirements (40 CFR, Part
158.2150) evaluate the potential for the MPCA to impact organisms beyond the
intended target pest(s). These studies require examination of pathogenicity on
related (e.g., other insects) and unrelated (e.g., plants, birds, and mammals) organisms.
The organisms chosen for study are functioning as surrogates, representative of
broader groupings (e.g., Mallard duck for birds in general), and include wild mammals,
birds, fish, beneficial insects, aquatic invertebrates, estuarine and marine organisms
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(fish and invertebrates), plants, and honeybee testing. In accord with 40 CFR, Part
158.30, the Agency has flexibility in determining which of these data requirements
must be in the form of generated data or related information, and which can be
satisfied by waiver rationale.
The Environmental Fate data requirements focus on the fate of the organism in the
area of application to determine the ability to persist and where the organism exists
(e.g., in soil, associated with insects, etc.). The survivability and host range of an organism are key to understanding the ability of an MPCA to persist in the environment and
potentially result in adverse effects (Hu and St. Leger 2002; 40 CFR 172.45(e)). For
example, release of entomopathogens may require monitoring of resident arthropods
to determine the ability to colonize and infect as a means of assessing persistence
(St. Leger et al. 1996). Reproduction (e.g., sporulation) on cadavers of target hosts or
lack thereof can be helpful in ascertaining the ability of the MPCA to persist following
small scale release. Rhizospheric competence was also assessed with another set of
constructs in M. anisopliae (now M. robertsii, J.F. Bisch., Rehner & Humber) as part of
an investigation into survivorship in the environment (Hu and St. Leger 2002).
As with all pesticides applied to food or feed crops, a food tolerance or the exemption
from the requirement of a food tolerance must be in place if any residues of the pesticide
may be present on any food derived from the crop. In all cases to date, the MPCAs
registered by the Agency have been granted an exemption from the requirement for a
tolerance based upon a determination that there is a reasonable certainty that no harm
will result from dietary exposure to the MPCA. In general, pesticides containing
elements of any of the eight major allergens are not approved for use on most food or
feed crops, which could also extend to any expressed proteins originating from peanuts,
tree nuts, milk, soybeans, eggs, fish, Crustacea, and wheat (40CFR 180.950).
While the same set of data requirements are imposed upon naturally occurring
and GE microbial agents, genetically modified MPCA and non-indigenous microbial species may be subject to additional data or information requirements on a
case-by-case basis depending on the particular microbial agent and/or its parental
strains, the proposed pesticide use pattern, and the manner and extent to which the
organism has been genetically modified (FR 2007).

4.2.1

Biotechnology Notification Process
for Microbial Pest Control Agents

At least 90 days prior to conducting any small scale test of a genetically modified
microbial pesticide, other than those described at 40 CFR 172.45(d), a Notification
must be submitted to the EPA in which the details of the genetic modification, proposed
application methods and sites, and any potential toxicity or non-target organism effects
are delineated. 40 CFR 172, subpart C. Measures must also be outlined in the
Notification submission which indicate the methods of containment and monitoring
used to ensure the GEO does not become established in the ecosystem. 40 CFR 172.48.
The data required to support a request for a Notification are detailed in 40 CFR Part
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172.48 (FR 59, 169, Sept. 1, 1994). If the proposed field test is to be greater than10
acres of treated land per pest evaluated or greater than1 acre, for aquatic uses, then an
experimental use permit is necessary. 40 CFR 172.3.
Under FIFRA, a Biotechnology Notification Process (40 CFR, Part 172.43; BNP)
for release of a GE-MPCA at any size test plot requires review and approval by the
EPA prior to commencing experimentation. EPA requires notification prior to small
scale field testing of genetically engineered and non-indigenous microorganisms not
subject to USDA oversight to allow EPA to determine if an Experimental Use Permit
is needed and to allow the applicant to gather data critical to the risk assessment process. Processing times for review and approval of BNP applications are considerably
shorter than those encountered with Experimental Use Permits (EUPs) and Section 3
registrations, and they are intended for smaller (e.g., £1 A) field test plots than EUPs.
It must be emphasized that with BNP approvals, any treated plants or materials are
prohibited from entry into the food and feed supply unless a food tolerance or exemption
from the requirement of a food tolerance under Section 408 of FFDCA is in place;
these environmental releases are strictly for research purposes only. The treated
produce of a BNP or EUP may be allowed for consumption by experimental animals,
however, the products of those animals are not allowed for entry into the food or feed
supply unless an appropriate food tolerance action is in place.
Several GE MPCA have been through the BNP successfully and field tested on a
small scale (See Table 4.1). This includes the first approved field test of a GE
microbe, strains of Pseudomonas syringae and Erwinia herbicola with an ice-minus
phenotype applied to potatoes as a means of preventing frost and its associated
plant damage (Lindow and Panopoulos 1988; Milewski 1987). Advanced Genetic
Sciences (AGS) had engineered a Ps. syringae resulting in the absence of expression
of a membrane protein responsible for ice nucleation, though the product currently
marketed as ‘Frostban®’ is not genetically engineered and is a naturally occurring
ice-minus strain. Another wildtype ice + strain of Ps. syringae is also marketed, as
‘Snowmax’ and is utilized in artificial snow-making operations, however, it is not
regulated as an MPCA.
Other successful BNP environmental releases include two Metarhizium
anisopliae strains modified to enhance virulence through addition of native protease
genes (St. Leger et al. 1996) and, in a separate BNP, a gene derived from the scorpion
Androctonus australis encoding a known neurotoxin active against tobacco hornworm
(Wang and St. Leger 2007).

4.2.2

Experimental Use Permits for Microbial Pest
Control Agents

When testing a MPCA at 10 acres or more (1 A or more for aquatic use), EPA requires
an Experimental Use Permit before field testing naturally occurring or genetically
engineered MPCA (40 CFR Part 158.2170; 40 CFR Part 172.3). EUPs for GE-MPCA
typically involve larger acreages than those approved under a BNP; however, pesticide

Clavibacter xyli subsp.
cynodontis
Pseudomonas fluorescens,
M-Cap™ b

Pseudomonas fluorescens,
MVP®b

Pseudomonas fluorescens,
M-One Plusb
Pseudomonas syringae
742RS/Ps. fluorescens
A506 and 1629RS
Pseudomonasb fluorescens,
Mattch™

Bacillus thuringiensis,
ECX9399
Nuclear polyhedrosis
virus of Autographa
californica
AcMNPV

1988

1987
1990

1990, 1991,
1994

1991

1993

1994, 1996

1993
1995

1992

1987

Pseudomonas syringae
RGP36R2 and Ps.
fluorescens GJP17BR2
Pseudomonas syringae

1985, 1987

Ice minus (absence of
membrane protein inducing
crystallization of water)
Ice minus (absence of
membrane protein inducing
crystallization of water)
Insecticidal Cry toxin from
B. thuringiensis var. kurstaki
CryI proteins from
B. thuringiensis
var. san diego
Chimeric Cry1Ac/
Cry1Cproteins from
B. thuringiensis var. kurstaki
CryI proteins from B. thuringiensis
var. san diego
Ice minus (absence of membrane
protein inducing
crystallization of water)
Cry IA(c)/CryIA(b) and CryIC/
CryIA(b) chimeric proteins
from B. thuringiensis
var. kurstaki
Cry proteins from
B. thuringiensis var. kurstaki
Insecticidal toxin AaHTI
from Androctonus australis
hector
Experimental
use permit
Biotechnology
notification

Experimental
use permit
Registration

Insecticide
Federal
Register (1995)
Insecticide
All et al. (1994)
Insecticide

Registration

Experimental
use permit
Experimental
use permit
Registration
Experimental
use permit
Registration
Registration

Biotech
notification

American Cyanamid

Ecogen

Frost Technology
Corporation
Plant Health Technologies
Mycogen

Mycogen

Mycogen

University
of
California – Berkeley
Crop Genetics
International
Mycogen

Advanced Genetic
Sciences

Regulatory action Registrant
Biotech
notification

Frost prevention

Insecticide

Insecticide
Navon (2000)

Frost prevention
Lindow and
Panopoulos (1988)
Insecticide
Turner et al. (1991)
Insecticide

Frost prevention
Smith (1997)

Table 4.1 EPA/FIFRA regulation of genetically engineered organisms for environmental release
Year
Organism
Trait
Intended use/ref
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1997

1996, 1997

1996

1996

1996, 1997

1996

Cry 1Ac/1 Fc protein from
B. thuringiensis var.
kurstaki/aizawai

Insecticidal toxin from Leiurus
quinquestriatus hebraeus

Nucleara polyhedrosis
virus of Autographa
californica AcMNPV
Bacillus thuringiensis
EG7673
Raven™ OF
Bacillus thuringiensis,
EG7841 Cry
Max® WDG/WP
Helicoverpa zea
single-embedded
nuclear polyhedrosis
virus HzSNPV
Nuclear polyhedrosis
virus of Autographa
californica AcMNPV
Nuclear polyhedrosis
virus of Autographa
californica
AcMNPV
Nucleara polyhedrosis virus
of Autographa
californica AcMNPV
Bacillus thuringiensis
EG7826 Lepinox™
WDG/G

1995, 1996,
1997, 1998

1995

Trait
Insecticidal toxin LqhIT2
from scorpion Leiurus
quinquestriatus hebraeus
Cry 3Bb and 3Aa proteins
from B. thuringiensis
var. tenebrionis
Cry 1C proteins from
B. thuringiensis
var. aizawai
Insect-specific toxin from
the venom of the scorpion
Leiurus quinquestriatus
hebraeus
Insecticidal toxin (TxP-I)
from Pyemotes
tritici, straw itch mite
Insecticidal toxin (TxP-I)
from Pyemotes
tritici, straw itch mite

Organism

Year

Intended use/ref

Insecticide
Federal
Register (1997)
Insecticide
Baum (1998)

Insecticide
Tomalski
and Miller (1991)
Insecticide
Tomalski
and Miller (1991)

Insecticide
Federal
Register (1997)

Insecticide
Baum (1998)

Insecticide
Federal
Register (1997)
Insecticide
Baum (1998)

Registration

Biotechnology
notification

Experimental
use permit

Experimental
use permit

Biotechnology
notification

Registration

Registration

Ecogen/Certis

DuPont

DuPont

(continued)

American Cyanamid

DuPont

Ecogen/Certis

Ecogen/Certis

American Cyanamid

Regulatory action Registrant
Biotechnology
notification
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Rhizobium and
Sinorhizobium

Escherichia coli K-12
derivative; heat-killed

Agrobacterium
radiobacter K1026
Metarhizium anisopliae,
ARSEF 1080
Pichia pastoris;
heat killed

1997

1998
2002

1999

2004

2001, 2004

Cryphonectria parasitica
ATCC 38755 ATCC 64671

Pseudomonas fluorescens,
M-Press®

1997

1999

Helicoverpa zea
single-embedded nuclear
polyhedrosis virus
HzSNPV

1997

Table 4.1 (continued)
Year
Organism
Trait

Reduced virulence gene from
mycovirus CHV1-Euro7

Removal of DNA transfer
function by deletion
Enhanced protease production,
Pr1 gene from M. anisopliae
Insecticidal Trypsin
Modulating Oostatic Factor

Insecticidal toxin from
Androctonus australis
AaH IT1 and prevent
expression of the ecdysteroid
UDP-glucosyltransferase
gene (egt)
Chimeric Cry1F/Cry1A(b)
toxin from B. thuringiensis
var. aizawai
Expressing genes for trifolitoxin
to outcompete soil bacteria
and a hydrogenase for
enhanced nitrogen fixation
Harpin protein
from Erwinia amylovora

Fungicide/Protectant

Bactericide, Plant
disease prevention
Insecticide
St. Leger et al. (1996)
Larvacide
for mosquitoes

Plant disease
prevention

Bactericide
Federal
Register (1997)

Biotechnology
notification
Biotechnology
notification,
Registration
(Technical
Product only)
Biotechnology
notification

Experimental
use permit
Registration
Registration

Biotech
notification

Experimental
use permit

Insecticide

West Virginia University

Bio-Care Technology
Pty Limited
Ray St. Leger,
Univ. of Maryland
Insect Biotechnology, Inc.

EDEN Biosciences Corp.

Eric Triplett, University
of Wisconsin-Madison

Mycogen

American Cyanamid

Regulatory action Registrant
Biotechnology
notification

Intended use/ref
Insecticide
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Escherichia coli K-12
derivative;
heat-killed

Metarhizium anisopliae,
ARSEF 549
Citrus tristeza
closterovirus

2005

2007

Trait
Harpin ab protein with components of hrpN and
hrpW (Erwinia amylovora),
popA (Ralstonia
solanacearum),hrpZ
(Ps. syningae)
Scorpion toxin from
Androctonus australis AaIT
Anti-microbial peptides

Intended use/ref

Bactericide, Plant
disease prevention
Folimonov et al. (2007)

Insecticide

Plant disease
prevention, growth
enhancement

Biotechnology
notification
Biotechnology
notification

Ray St. Leger,
Univ. of Maryland
Southern Gardens Citrus,
University of Florida

EDEN Biosciences Corp.

Regulatory action Registrant
Registration

a
See SIDEBAR No. II.A, BIOCONTROL USING A VIRUS (AcMNPV) following the Bt-maize case study. http://www.whitehouse.gov/files/documents/ostp/
Issues/ceq_ostp_study3.pdf. Accessed 22 Nov 2010
b
Cry proteins expressed in Ps. fluorescens cells, cells then killed prior to application
c
Cry fusion protein

2011

Organism

Year
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products used under an EUP also require an approved label for experimental use and
interstate shipment (40 CFR Part 172.6); this is not the case for BNP testing. Several
genetically modified biopesticides have been approved for use under EUPs; but, a number
of these were never actually applied or in some cases only sparingly applied (Table 4.1).
The reasons for this relate to issues of public perception (i.e., is the company or researcher
willing to deal with public meetings and scrutiny?) and business decisions (e.g., is there
sufficient market potential to warrant the development and regulatory costs?).
The data requirements for an EUP involving GE-MPCA are discussed at 40 CFR
Part 174.3 and the specific tests, also germane to non-GE MPCA, are described in
158.2171–158.2174. In general, the data requirements for an EUP or Section 3
registration are similar, however, the limited exposure to the environment from the
small scale field testing of an MPCA under an EUP does not require the same level
of non-target organism testing as when full commercial registration is approved
through registration procedures. This is due in large part to the limited scope of the
environmental release at the EUP stage and the fact that much of the non-target
effects information may be collected as part of the EUP overall plan.

4.2.3

Section 3 Registration of Microbial Pest Control Agents

Before any microbial pesticide registration is granted under FIFRA, EPA considers
such issues as potential adverse effects to non-target organisms, environmental fate
of the microorganism, and the potential toxicity, pathogenicity and infectivity of the
microorganism to humans and other animals. These issues are the same as those
considered for non-engineered microbial agents approved for pest management,
and reflect the inherent similarities of the functional properties of the organism
regardless of whether the traits of primary interest are derived from rDNA or not.
The data requirements for registration of a microbial biopesticide are delimited in 40
CFR 158.2120–158.2150. The data and information garnered from the fulfillment of
these data requirements are used to inform the risk assessment process, just as with the
EUP and BNP applications. All of the data requirements must be satisfied for a FIFRA
Section 3 registration, however, in some instances rationale can be provided by the
registrant to explain why the requirement is not applicable to the MPCA in question.
For example, a psychrotropic bacterium which does not grow at temperatures greater
than 20 °C is unlikely to result in mammalian pathogenicity given the body temperature
of these animals, including man. Similarly, a microbial biopesticide labeled for use at
residential sites only is unlikely to result in significant exposure to marine and estuarine
environments. Explanation of factors affecting the applicability of a study outcome to a
risk determination may be used to satisfy some data requirements. As always, it is
important to discuss this with regulators prior to conducting any studies.
Relative to a BPN or an EUP, the number of studies requiring empirical data
generation applied to the issuance of a Section 3 registration are typically greater as
this regulatory action often coincides with commercial use on a larger scale than
either of the two preceding regulatory actions. For both BPN and EUP actions, the
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scope of the exposure of man and the environment to the novel pesticide is
significantly reduced as compared to commercial use in most instances. Hence, the
data and information required for an EUP or small scale field test under a BPN are
more often limited to concerns of human health (e.g., infectivity) and environmental
persistence than with longer term non-target effects, which will be addressed at the
time of registration, with data obtained through earlier field tests in most cases.
It should be noted that all pesticide registrations are subject to periodic review
and re-registration procedures as FIFRA is a licensing statute and statutory requirements exist in order to maintain that license or registration in good standing in order
to enter the product into commerce.
The first genetically engineered MPCA registered under FIFRA was a pair of
Pseudomonas fluorescens strains, each modified with a different type of d-endotoxin
from B. thuringiensis, for insect control. Mycogen chose to express their kurstaki
and san diego type endotoxins in Ps. fluorescens to provide for adequate expression
and accumulation of protein toxin, but also as a means of reducing inactivation of
these proteins by ultraviolet light. These products were referred to as MVP and
M-Trak, respectively, and did not contain any live organisms, so the risk assessment
was not concerned with pathogenicity or infectivity issues.

4.3
4.3.1

Risk Assessment Considerations
FIFRA

As noted above, FIFRA’s standard for registration decisions involves an assessment of
risks and benefits of using a pesticide. This is to include a biological analysis of potential
effects upon man and the environment as well as social and economic considerations
resulting from a regulatory decision. The inclusion of an explicit risk-benefit calculation
distinguishes FIFRA from most other U.S. environmental statutes.
One of the primary benefits of a biopesticide is the replacement of control
measures that may pose greater risks, such as groundwater contamination, toxicity
to non-target organisms, or dietary risks to infants and children. To date, decisions
to approve nuclear polyhedrosis viruses (NPVs), plant viruses and bacteriophage
have relied primarily on their lack of toxicity to all organisms except target pests
with little or no animal testing conducted. EPA considers possible benefits that
might result from use of viruses such as the NPV AcMNPV/LqhIT2 (OSTP 2001).
Application of AcMNPV/LqhIT2 would likely reduce the use of other insecticides
and thereby would avoid the types of impacts those less specific insecticides might
have had, if applied to the same acreage as AcMNPV/LqhIT2.
Targeting an insect-specific toxin to the ‘point of feeding’ of pest insects should
minimize the impact on non-target organisms and minimize ground water contamination, as may occur with use of more environmentally persistent chemical pesticides.
Because many of the previously deployed insecticides were broad-spectrum in their
activities, the potential for impacts on the beneficial insect populations was significant.
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Populations of beneficial insects should increase over time as more MPCAs with
host specificity are used and fewer broad-spectrum pesticides are applied. This has
been shown in the context of B.t. corn crops, where increased abundance of arthropods was noted in B.t crop fields when compared to conventionally bred maize treated
with insecticides (Marvier et al. 2007). Since some insecticides have effects on noninsect organisms (e.g. earthworms, nematodes), the reduction or elimination of these
broad-spectrum pesticides will help to nurture these populations as long as cultural
practices of soil management are adequate.
Additionally, the exposure of farm workers, pesticide applicators and the public
at-large is often reduced when a biological pesticide takes the place of a chemical
spray alternative. For example, residues on food are less of a concern with AcMNPV/
LqhIT2, because the insect neurotoxin is known to be non-toxic to humans and
other mammals. Spray drift is often problematic with chemical applications, but this
is not a significant issue with target specific NPVs.
FIFRA also requires special consideration of public health pests, such as disease
vectoring mosquitoes, cockroaches and rodents. Data detailing the ability of the
MPCA to manage a pest situation are required for all registrations, however, these
data must be submitted and reviewed for those involving public health pests prior to
any such regulatory action being considered.

4.3.2

FFDCA

The Federal Food, Drug, and Cosmetic Act is largely the purview of the US Food and
Drug Administration, except for residues of pesticides that may occur in food and feed
(Section 408, FFDCA). Microbial biopesticides that pass Tier I testing without evidence
of toxicity or pathogenicity will most often qualify for an exemption from the requirement of a numerical food tolerance (also referred to as a Maximum Residue Level in
some countries). This regulatory action, determined following risk assessment and
literature review, has afforded the determination that any level of the microbe present in
food and feed resulting from use of the product as specified on the FIFRA label, will not
result in harm by a variety of exposures. Among the exposure scenarios assessed for
food safety are ingestion through food or water, inhalation, dermal and eye contact,
and injection. While effects may be evident in some of these tests, the probability of
exposure is also a consideration. Specific areas addressed under FFDCA (as applicable
to microbial pesticides) are acute, subchronic and chronic dietary risks, occupational
exposures, drinking water exposures, effects to the immune and endocrine systems, any
dose response related information, exposures associated with day cares, residences and
schools, exposure of sensitive populations, such as infants or children, aggregate effects
for multiple exposures, and cumulative effects.
When assessing MPCA, there are the three endpoints of concern: infectivity,
pathogenicity and toxicity. In some cases an analysis of potentially toxic metabolites
is included in the food safety risk assessment and review of the primary literature.
Some microbial species are known to produce metabolites or toxins which can have
adverse effects upon man and livestock following consumption.
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Note, if an organism is not completely identified or is closely related to a human
pathogen, i.e., in the same genus, the literature review and subsequent risk assessment
should be broad enough to cover the eventuality that the relevant pathogenicity
factors and/or toxins are ruled out as not present in the test strains proposed for use
as a pesticide.

4.4

Entomopathogenic Nematodes

Entomopathogenic nematodes have been applied to pest management of insects in
diverse agricultural settings (de Doucet et al. 1998; Head et al. 2000; Martin 1997).
While the number of nematode genera infecting insects and other arthropods is
large and diverse, most of the research and development interest has been with the
Steinernematid and Heterorhabditid groups targeting agricultural insect pests
(Grewal and Peters 2005). Both of these genera rely on symbiotic (phoretic) bacteria
to effect a lethal septicemia upon their hosts which results in degradation of internal
tissues and organs, death of the insect host, and reproduction of the nematode and
symbionts.
Members of the genera Steinernema and Heterorhabditis differ in their strategies of host location, host specificity, and survival mechanisms, they are both
inherently susceptible to heat and desiccation in the soil environment. As a means
of enhancing the heat tolerance of Heterorhabditis bacteriophora, an hsp70A gene
from Caenorhabditis elegans was introduced to juvenile nematodes (Hashmi et al.
1995; Wilson et al. 1999). Although this effort was ultimately not successful at the
field level in providing the necessary level of heat tolerance, it nonetheless raised
some interesting regulatory issues (Gaugler et al. 1997).
The Code of Federal Regulations defines microorganisms considered as biopesticides to include viruses, bacteria, protozoa, algae and fungi (FR 2007). Absent
from this list are nematodes and certain other microscopic, multicellular invertebrates.
Nematodes may be included as biocontrol agents subject to oversight under the
Plant Pest Act, yet this is less than apparent.
According to the Coordinated Framework for Biotechnology (OSTP 1986) when
referring to EPA’s oversight, “The Agency has determined that certain non-microbial
organisms which fall within the definition of biological control agents are already
addressed by other agencies, specifically USDA and the Department of the Interior.
Examples of these biological control agents are vertebrates, insect predators, nematodes,
and macroscopic parasites. Therefore, pursuant to section 25(b) of FIFRA and 40
CFR 162.5(c)(4), these nonmicrobial biological control agents have been exempted
from regulation under FIFRA. However, if EPA, in cooperation with other agencies,
determines that certain biological control agents exempted by § 162.5(c)(4) are not
being adequately regulated, these organisms will be referred to the attention of
the appropriate agency or added to the exceptions in § 162.5(c)(4) by amendment.
In the latter case, those organisms would no longer be considered exempt from the
provisions of FIFRA.”
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While entomopathogenic nematodes are included in this exemption, genetic
engineering of either the nematode or the microbial symbiont could bring the new
product back under FIFRA oversight as a pesticide.
Genetic engineering of the microbial symbionts (i.e., Xenorhabdus spp.;
Photorhabdus spp.) would bring these organisms under the regulatory umbrella of
the USDA-APHIS and EPA, however, modification of the nematode itself does not
meet existing regulatory thresholds (FR 2007; Gaugler et al. 1997; Gaugler, personal
communication). It should be noted that in the U.S., the importation and interstate
movement of exotic entomopathogenic nematodes may be regulated by the USDAAPHIS’ Plant Protection and Quarantine group (Rizvi et al. 1996; Selçuk et al. 2003)
under the Plant Protection Act of 2000.
During laboratory and growth chamber experimentation with the H. bacteriophora
hsp70A transformants, this issue was raised to the USDA-APHIS and EPA-BPPD for
clarification (Randy Gaugler, personal communication; Chris Wozniak, personal
communication). At the time, neither agency indicated jurisdictional oversight of
these GE nematodes, but suggested that the Center for Disease Control be contacted
as well. Communication with CDC (Wozniak, personal communication) likewise
indicated that they did not claim oversight of the organisms for the intended purpose
(i.e., pest control).
Faced with this lack of Federal oversight, yet concerned with public perception
and local (i.e., State, University Institutional Biosafety Committees) considerations,
the lead investigator, Dr. Randy Gaugler of Rutgers University, requested a review
of the H. bacteriophora hsp70A, as applied to insect pest management, by the
USDA-APHIS. This review resulted in a finding of no significant impact (FONSI)
by the agency and a determination that environmental release would not result in
injury to agricultural plants or their products as determined under the Plant Pest Act.
Note that this finding does not preclude potential regulatory action by State or other
local authorities, as is the case with all microorganisms, including pesticidal agents,
intended for release into the environment.
While the lack of Federal regulation has obviously reduced costs and time
necessary to bring an entomopathogenic nematode product to market, some have
opined that this lack of oversight has resulted in some inferior products with
exaggerated claims (Weinzierl et al. 2005). At least one of the authors (CAW)
has had this unfortunate experience!

4.5
4.5.1

Considerations of Genetic Engineering and Gene Transfer
Public Perception of GE Microbials

During the early stages of the development of GE microorganisms, significant public
debate occurred regarding the human health and environmental safety of these novel
products of biotechnology (Marchant 1988; Barinaga 2000). As is often the case with
public reaction to new technologies, the debate was not always centered on scientific
facts or reasoned discussion, but was taken up by opponents of biotechnology as a
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crusade against development of genetically engineered organisms regardless of intent
or merit. Additionally, debate within the scientific community was needed to develop a
regulatory system capable of responding to novel products and nuances to the technology
as they developed. As evidenced by the early field experiments with ice-minus bacteria
for frost prevention on strawberries and potatoes (Crawford 1986; Marchant 1988;
Barinaga 2000), or the intentional degradation of an oil spill by hydrocarbon munching
pseudomonads (Van 1989), public and, therefore, political considerations have
influenced the field release and commercialization of GE microbes. Others have also
expressed concerns (Dixon 2008).
Consideration of public perception and understanding of this novel technology led
to business decisions that apparently did not necessarily reflect the actual science or
potential risk associated with the proposed release of a particular GE microbial pest
control agent. As is the case with GE plants, commercial considerations and the threat
of lawsuits, with or without merit, persuaded individual concerns to halt research and
development programs that may have lead to more environmentally benign alternative
pest management measures (Phil Hutton Personal communication). Although regulatory
requirements by EPA and USDA-APHIS may result in greater costs and longer lead
times for commercialization of GE microbial products, we believe that, at least in
some cases, companies were seeking regulatory approval as a means of indicating the
safety of these products and did not perceive regulatory requirement as a deterrent to
application of the products to market (Wrubel et al. 1997). Given the furor over the
ice-minus and concurrent microbial field tests, regulatory oversight and approval may
have enhanced public acceptance.
Many years later, as genetic engineering technology has progressed, significant
numbers of GE microbial pest control agents exist on the market without the fanfare
and protests characteristic of the early years of this technology. We believe that this
bodes well for the potential of this technology to reduce the application of less
environmentally benign technologies that ultimately have the potential for greater
environmental effects.

4.5.2

Future for GE Microbials in Pest Management

The field of agricultural biotechnology has grown and developed so rapidly in the last
20 or so years that avenues to be taken, which we had not even anticipated 5 or
10 years ago, will continue to astound us in the future. The majority of this activity, at
least in traditional agricultural terms, has been directly through engineering of plants
for a variety of purposes, while the application of rDNA technology to microbial
agents for pest and disease control has been slow in comparison. As can be evidenced
by Table 4.1, the number of research efforts aimed at pest control through genetic
engineering of MPCA have been numerous over the years. But, these efforts appear to
have slowed, as recent actions are relatively few. There is, however, reason to expect
that this may change in the future, at least in US and Canadian applications.
Despite the fact that some individuals are uncomfortable with microbes in general, based largely on a lack of understanding and encouraged by germ phobias, the
instances where genetically engineered microbials have been utilized for nitrogen
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fixation, soil amendments, biological control, and in bioremediation have not garnered
the negative publicity to the degree that GE crop plants developed for agronomic,
quality trait, and pest control purposes have. This was clearly not the case early on
with the advent of biotechnology in agriculture – as was demonstrated by the furor
over the early ice-minus field trials with pseudomonads in California or the first release
of oil-degrading bacteria for cleanup of petroleum spills in marine environments.
The lack of attention to GE MPCA and other microbials may be in part due to the
continued rancor over GE crops. There is also a common thread of mistrust among
some of these groups toward large corporate interests (i.e., seed companies) such
that the continued research and application of GE microbes flies largely under the
radar of those who claim an innate aversion to this most promising of modern
technologies. The majority of GE MPCAs are developed by small to mid-size
companies without the visibility of those heavily involved in crop biotechnology.
One must also consider the use of GE microbes in food processing (e.g., chymosin,
ascorbic acid production, flavor enhancers), even in countries where biotechnology
is publically and officially shunned by many (e.g. the EU; GMO Compass 2010).
These organisms and their products, when used as food processing aids, fail to trip
the regulatory requirement for food labeling in stark contrast to those food and feed
products derived from products of crop biotechnology. Perhaps this level of familiarity
has garnered some trust with consumers or it simply has not made news enough
to be noticed. Either way, it could bode well for GE microbial agents applied to
agriculture and the environment.

4.6
4.6.1

TSCA Risk Assessment of Intergeneric Microorganisms
TSCA Regulation of Microorganisms

The United States Environmental Protection Agency is responsible for reviewing
the risks associated with the commercial use or importation of chemical substances,
including certain genetically modified microorganisms, under Section 5 of the Toxic
Substances Control Act (TSCA). TSCA specifically excludes from review certain
products that are subject to review by other federal agencies or under other statutes,
including tobacco, nuclear materials, pharmaceuticals and cosmetics, and pesticides
(but not pesticidal intermediates). TSCA’s regulation of microorganisms is limited
to those microorganisms that are “new”, meaning that they are not listed on the
TSCA Inventory of Chemical Substances. In this context, “new” microorganisms
have been defined as those that are intergeneric, meaning that there has been the
deliberate combination of genetic material originally isolated from organisms
classified in different taxonomic genera. Also included in the definition of an intergeneric
microorganism is a microorganism constructed with synthetic genes that are not identical
to DNA that would be derived from the same genus as the recipient microorganism.
Exclusions from TSCA review include naturally occurring microorganisms, as they
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are considered to be implicitly listed on the TSCA Inventory, genetically engineered
microorganisms other than intergeneric (e.g., intrageneric, physical or chemically
mutagenized microorganisms), and intergeneric microorganisms resulting only
from the addition of well-characterized, non-coding regulatory regions. TSCA section
5 only applies to microorganisms that are manufactured, imported, or processed for
commercial purposes.
Intergeneric microorganisms subject to review under TSCA include a wide variety
of biotechnological applications since TSCA is a gap-filling statute for biotechnology
products not regulated under other statutes. Intergeneric microorganisms that may
be subject to review under the Biotechnology Rule (40 CFR Parts 700,720, 721,
723, and 725 Microbial Products of Biotechnology: Final Regulation Under the
Toxic Substances Control Act, FR Vol 62 No. 70 17909–17958, April 11, 1997)
may be in applications including but not limited to biofuel production, biomass
conversion, waste treatment, bioremediation, biomining, mineral leaching, oil
recovery, desulfurization of fossil fuels, biofertilizers, biosensors, closed system
fermentation for the production of enzymes and specialty chemicals, and pesticidal
intermediates. Among these, biofertilizers (e.g., nitrogen fixers, mycorrhizae, phosphate
solubilizers, etc.), algal biofuels, pesticidal intermediates, and perhaps, biosensors
could have agricultural uses.

4.6.2

Categories of Premanufacturing Oversight

4.6.2.1

Microbial Commercial Activity Notice (MCAN)

Prior to manufacture or importation of an intergeneric microorganism, companies must
make an appropriate submission to EPA’s Office of Pollution Prevention and Toxics
(OPPT). Subpart D of part 725 of the Biotechnology Rule establishes the reporting
program for new microorganisms. New microorganisms that are to be manufactured or
imported for distribution into commerce requires the submission of a Microbial
Commercial Activity Notice (MCAN) 90 days prior to initiating manufacture or import,
unless the activity is eligible for one of the specific exemptions.
The purpose of the MCAN is to supply EPA with information necessary to identify and list the new microorganism on the TSCA Inventory of Chemical Substances,
and to determine whether the microorganism and the associated manufacture or
importation may present an unreasonable risk of injury to human health or the
environment. The MCAN information requirements closely parallel those developed
for traditional chemical Premanufacturing Notices and differ only to the extent
necessary to accommodate the specific characteristics of living microorganisms
versus chemicals. All information on the microorganism identity and data on its
actual and potential effects on human health and the environment that are available
to the submitter, or are reasonably ascertainable are required in the MCAN. A detailed
description of the genetic modifications to the recipient microorganism is necessary,
along with data on the stability of inserted genetic material in the production strain
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and the potential for transfer of this material to other organisms in the environment.
In addition, a detailed complete description of the manufacturing process and
design, production volumes, and containment and inactivation procedures are
required. The requirements for information to be included in the MCAN are codified
at § 725.155 and § 725.160.

4.6.2.2

Exemptions from Full Premanufacturing Notification

Research and Development Exemption
One exemption from MCAN reporting is the R&D Exemption. This is a complete
exemption from TSCA § 5 reporting for certain R&D activities that are (1) conducted
in contained structures, and (2) are subject to regulation by another Federal agency.
As discussed in Subpart E of the Biotechnology Rule and codified at § 725.232,
activities that meet these criteria are exempt from EPA review, reporting, and record
keeping requirements for contained research conducted by researchers who are
required to comply with the NIH Guidelines for Research Involving Recombinant
DNA Molecules (http://oba.od.nih.gov/rdna/nih_guidelines_oba.html).
Other manufacturers conducting contained TSCA research and development
activities that are not subject to regulation by the NIH Guidelines may qualify for a
more limited contained R&D exemption under § 725.234 and § 725.235. This
exemption for R&D in contained structures specifies factors that a technically
qualified individual (TQI) must consider in selecting the appropriate containment
for this exemption. A structure is defined as a building or vessel which effectively
surrounds and encloses the microorganism and includes features designed to restrict
the microorganism from leaving. In proposing the Biotech Rule, EPA envisioned
that this exemption would most likely apply to research performed in contained
structures such as buildings, including laboratories, greenhouses, and pilot fermentation plants. etc., and in certain bioreactors used for waste treatment. However,
other forms of structures could be used. EPA’s approach relies on the experience
and judgment of the TQI, recognizing that many different kinds of microorganisms
displaying a wide range of characteristics could potentially be used in research.
It also recognizes that appropriate types of controls (e.g., procedural. mechanical.
and/or engineering) will vary with the microorganism and type of research. EPA
expects that the TQI will be cognizant of these factors when selecting containment
and inactivation controls appropriate to the microorganism(s) being utilized. The technically qualified individual is required to keep records to document both compliance
with the containment requirements and compliance with the notification process for
employees involved in the R&D process.
A major consideration of the R&D exemption in a contained structure is the structure itself. EPA may interpret the definition of a structure broadly given the intention
of freely permitting research with contained microorganisms that meet the criteria of
§ 725.234. However, EPA encourages potential researchers who wish to perform
their research in atypical contained structures to confer with EPA prior to initiating
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their effort to confirm that the structure is considered “contained”. There may be
instances in which a TSCA Environmental Release Application (TERA), which is a
submission for field testing or intentional environmental release, may be required if
the structure is not deemed “contained” (see below for TERA requirements).

Tier I and Tier II Exemptions
There are exemptions from MCAN reporting for certain industrial microorganisms
used in closed systems so they likely have limited, if any, relevance to typical agricultural applications. As described in Subpart G, these Tier I and Tier II exemptions
for closed systems are based on a three-pronged approach: use of a microorganism
with a history of safe use, criteria that ensure the safety of the introduced DNA, and
conditions for containment and inactivation of the microorganism to ensure low
releases from the manufacturing/production facility. To qualify for the Tier I exemption,
a manufacturer must use one of the ten recipient organisms listed at § 725.420 that
have undergone categorical risk assessment, or any such microorganism subsequently
listed after promulgation of the Biotechnology Rule through a petition process
described in § 725.67. Currently, the eligible recipient microorganisms include the
five bacteria Acetobacter aceti, Bacillus licheniformis, Bacillus subtilis, Clostridium
acetobutylicum, Escherichia coli K-12, and the five fungi Aspergillus niger, A. oryzae,
Penicillium roqueforti, Sacharromyces cerevisiae, and S. uvarum. In addition to the
use of an approved recipient microorganism, there are four criteria for the genetic
material introduced into these strains. There are also specific criteria for releases
from the manufacturing facility and for inactivation of liquid and solid waste streams.
For those manufacturers meeting Tier I requirements, only a brief notification to the
Agency stating that fact is necessary. A manufacturer, who meets only the first two
conditions of the Tier I exemption, but not the containment and inactivation criteria
must submit a Tier II exemption notice to the Agency for a review of the process
design and containment/inactivation conditions appropriate for the intergeneric
microorganism.

Test Marketing Exemption (TME)
Another exemption from MCAN reporting requirements is the Test Marketing
Exemption (TME) noted at § 725.300. Test marketing activities usually involve
limited sale or distribution of a substance within a predetermined period of time to
determine its competitive value when its market is uncertain. In general, EPA suggests
that manufacturers who intend to test market a new microorganism file a MCAN
rather than request a Test Marketing Exemption. However, there may be situations
in which this exemption is appropriate, such as for microorganisms which were
previously reviewed by EPA at the R&D stage. In addition to the general administrative
requirements, certain technical information is required for each TME submission
as noted in § 725.350 and § 725.355.
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TSCA Experimental Release Application (TERA)

Another exemption from MCAN reporting requirements is available for R&D
activities. The TSCA Experimental Release Application, described in Subpart E at
§ 725.238, is an exemption for R&D involving an intentional environmental release
of an intergeneric microorganism. This exemption is likely to be a common one for
many agricultural uses (e.g., biofertilizers, algae for biofuel production), as they
generally involve field tests or may involve some release of subject microorganisms.
Also, as previously mentioned, a TERA may be necessary for some contained R&D
activities if such R&D is conducted in an atypical structure that does not meet the
regulatory definition of a contained structure. The TERA is essentially an abbreviated MCAN for a field test or other intentional environmental introduction with a
shortened review period of 60 days, although EPA may extend the review period for
good cause. EPA must approve the TERA, with or without conditions, before the
researcher may proceed, even if the 60-day period expires. EPA’s approval is limited
to the conditions outlined in the TERA notice and approval for the specific field test
at the specified site(s).
A TERA must contain all available data in the possession or control of the submitter or reasonably ascertainable by the submitter on the microorganism(s) and the
research and development activities that will allow EPA to make a reasoned evaluation of the planned test in the environment. The TERA must contain microorganism
identity information and all available data concerning actual or potential effects on
health or the environment of the new microorganism along with the phenotypic and
ecological characteristics of the microorganism as they relate directly to the conditions
of the proposed R&D activity. Persons applying for a TERA must also submit
information about the proposed field testing activity including the objectives and
significance of the activity with a rationale for testing in the environment, the numbers
and frequency of microorganisms released by the proposed application method(s),
the presence of target organisms, if applicable, and a full characterization of the test
site(s) including location, geographical, physical, chemical, and biological features,
and proximity to human habitation or activity. Also needed is a description of
confinement procedures, mitigation and emergency procedures, and procedures for
routine termination of the activity. The exact information requirements for a TERA
are codified at § 725.255 and § 725.260.

Exemptions from a TERA for Eligible Microorganisms
There is an exemption from TERA reporting requirements for R&D field testing of
two microorganisms with which EPA has had sufficient experience to determine
that a submission is no longer needed. The exemption applies to two eligible microorganisms, Bradyrhizobium japonicum and Sinorhizobium (formerly Rhizobium)
meliloti) providing certain conditions of the microorganisms and of the field testing
are met. The introduced genetic material must comply with certain restrictions, the
field testing must occur on no more than 10 terrestrial acres, and appropriate
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containment measures must be selected to limit dissemination (see § 725.238 and
§ 725.239).
This TERA Exemption requires no upfront reporting to EPA, although a
certification statement and recordkeeping are required. Guidance on how to submit
a certification statement to EPA and on the recordkeeping requirements for field
tests with these bacteria is provided at § 725.238.

4.6.3

Risk Assessment Process

Within the specified time period for each type of submission, EPA staff conduct a
risk assessment on the intergeneric microorganism under the paradigm that
Risk = Hazard × Exposure. There are a number of separate assessments made that are
integrated into a final risk assessment. The components of the risk assessment include
(1) a verification of the identification of the subject microorganism, (2) a human
health hazard assessment, (3) an ecological effects hazard assessment, (4) a report
that analyzes the construction of the microorganism and summarizes the pertinent
chemical information and production volume known as the chemistry report, (5) an
analysis of the genetic construct that evaluates any potential hazards associated with
the genetic modifications and the potential for horizontal gene transfer, (6) an
engineering report that assesses worker exposure and microbial releases to the
environment through manufacturing or during field applications, and (7) an exposure
assessment that evaluates the potential for survival, reproduction, and dissemination
of the microorganism, and the exposure of the microorganism to environmental
receptors and to the general population.
As noted below, there is no provision for a specified schedule of information
elements under TSCA. Rather submitters must provide to EPA all relevant data and
information in their possession or reasonably ascertainable. These data must be
sufficient to enable EPA to complete a risk assessment. If a submission of any type
contains insufficient information to proceed with a review, EPA may request an
extension from the submitter to allow the submitter to provide the necessary information.
EPA also has risk management options that may be employed to mitigate the effect
of uncertainty due to data or information limitations as described below.
Since TSCA is a risk-benefit statute, the risks of using the microorganism
determined in the risk assessment are weighed against the benefits to society (that
are evaluated in an economics analysis) to arrive at the final risk management
decision. Possible outcomes of the review process include a determination that there
is (1) sufficient information to determine that the microorganism presents “no
unreasonable risk of injury to human health or the environment” in which case the
Agency takes no regulatory action and the company may commence manufacture
after 90 days, (2) sufficient information to determine that the microorganism presents
“an unreasonable risk of injury to human health or the environment” which means
the Agency would take regulatory action to prohibit or restrict the production or use
of the microorganism, and (3) insufficient information to determine effects, but the
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possibility exists for unreasonable risk and/or substantial/significant exposure, in
which case the Agency may negotiate a Section 5(e) Consent Order to restrict the use,
and to specify the data needed to lift the Consent Order. The key element to the
possible outcomes of EPA’s review process is the amount of information that the
Agency is supplied with or can obtain concerning the microorganism in order to
make a determination of whether or not the use of the microorganism presents an
unacceptable risk of injury to human health or the environment.

4.6.4

Data and Information Needs

Unlike many other statutes under which biotechnology products are reviewed,
TSCA does not have specific initial data requirements. Rather, the submitter is
required to provide relevant data and information that are available or reasonably
ascertainable with the notification to EPA. In contrast, with microbial pest control
agents (MPCAs) which are reviewed by EPA’s Office of Pesticide Programs (OPP)
under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), there are a
number of specific pathogenicity/toxicity/infectivity tests that must be conducted
and submitted to the Agency. MPCAs, by their very nature, are designed to be either
pathogenic or toxic to some pest, and consequently, their effects of pathogenicity/
toxicity are fairly straightforward. The microorganisms that fall under TSCA review
differ in that most are not likely pathogenic or toxic, but primarily are benign recipient
microorganisms genetically engineered to synthesize a particular product or accomplish a particular task or transformation.
Obtaining sufficient information about the submission microorganism from the
manufacturer or importer so that a scientifically credible risk assessment can be
conducted by the Agency is critical to the review process. Information needs match
the set of individual assessments (e.g., human health, ecological effects, etc.) that go
into the comprehensive risk assessment described previously. Since combinations of
microorganism and proposed use can vary widely, EPA prepared a guidance document,
“Points to Consider in the Preparation of TSCA Biotechnology Submissions for
Microorganisms, June 2, 1997” (hereafter referred to as the Points to Consider
document). This document is intended to assist manufacturers or importers in providing
EPA’s Office of Pollution Prevention and Toxics with both appropriate and sufficient
information for EPA to conduct a robust risk assessment. It is intended that the Points
to Consider document be a “living document” in that it will be updated periodically to
reflect state-of-the-art biotechnological applications, risk assessment methodology,
and current knowledge of microbial processes and characterization.
Although there are no data requirements that are applied routinely to each case,
information that is both accurate and sufficient is necessary to evaluate the risks
posed by the manufacture and use of genetically modified microorganisms. Each
submitter must supply, as part of its notification requirements, all relevant data
and information in its possession, or that is otherwise reasonably ascertainable.
Information available in the literature or from sources other than the submitter is also
used by the Agency in the evaluation of the hazards posed by the microorganism
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and its ability to survive in the environment. The effects of genetic modifications of
the recipient microorganism are then evaluated. For instance, if a recipient bacterium
is known from the literature not to be a frank human pathogen, then it is unlikely
that the introduction of one or several genes will create a pathogenic microorganism
de novo. Likewise, if from the literature it is known that the recipient microorganism
survives well in the environment, then the intergeneric microorganism also might be
expected to survive well depending on whether the genetic modification altered any
genes key to its survival characteristics. The Points to Consider document has been
provided to guide submitters in selecting all the relevant information that the Agency
may need for the review of all possible types of microorganisms and applications
that may be subject to review under TSCA. All of the points or issues in the guidance
document may not be appropriate for all cases. This document is not a schedule of
data requirements but rather essentially a menu of data elements from which submitters
are expected to choose the ones relevant to their particular microorganism and
application. For example, information on substrate range and metabolic pathways
may be applicable for a microorganism designed for bioremediation, but would be
irrelevant for a microorganism designed for symbiotic nitrogen fixation. Identification
of possible nontargets, i.e., potential legume hosts, may be important for symbiotic
nitrogen-fixing rhizobia, but irrelevant to a microorganism used in a closed system
for making an algal biofuel.

4.6.5

4.6.5.1

Applications of Genetically Engineered
Microorganisms Reviewed to Date
Past Applications

A wide variety of intergeneric microorganisms have been reviewed under TSCA
since the mid 1980s. Prior to the promulgation of the Biotechnology Rule in 1997,
intergeneric microorganisms with TSCA uses were reviewed on a voluntary basis
under the chemical Pre-Manufacturing Notification (PMN) system. Those intergeneric microorganisms and their genetic modifications with relevance to agriculture
are listed in Table 4.2.
Following the promulgation of the Microbial Biotechnology Rule, various submissions types discussed above for intergeneric microorganisms have been received
by the Agency. The majority of the submissions reviewed by EPA since publication
of the Biotechnology Rule have been for closed system fermentation for enzyme
production which were not relevant to agriculture, and thus, will not be elaborated on
here. A complete list of all intergeneric microorganisms reviewed under TSCA to
date can be obtained on the Biotechnology Program’s website (http://www.epa.gov/
oppt/biotech) under Notifications.
Table 4.3 presents those intergeneric microorganisms reviewed by EPA under
TSCA since the promulgation of the Biotechnology Rule, having relevance to
agriculture, all of which were TERA submissions.

BioTechnica
International, Inc.
Monsanto Agricultural
Company

1987

Mycogen Corporation

Research Seeds, Inc.
(purchaser of BioTechnica
Agriculture, Inc. strains)

1991

1992

1992

1990

1989

1989

1988

BioTechnica,
Agriculture, Inc.
BioTechnica,
Agriculture, Inc.
BioTechnica,
Agriculture, Inc.
BioTechnica,
Agriculture, Inc.
BioTechnica,
Agriculture, Inc.
Mycogen Corporation

1988

1987

Company

Fiscal year

Five strains of Rhizobium meliloti
(Sinorhizobium meliloti)

Sixteen strains of Pseudomonas
fluorescens

Three strains of Rhizobium meliloti
(Sinorhizobium meliloti)
Pseudomonas aureofaciens
(currently Pseudomonas
chlororaphis)
Eight strains of Rhizobium meliloti
(Sinorhizobium meliloti)
Four strains of Rhizobium meliloti
(Sinorhizobium meliloti)
One strain of Rhizobium meliloti
(Sinorhizobium meliloti)
Two strains of Bradyrhizobium
japonicum
One strain of Rhizobium meliloti
(Sinorhizobium meliloti)
Two strains of Pseudomonas
fluorescens

Recipient microorganisms

Nitrogen fixation genes and
antibiotic resistance genes

Delta endotoxin genes from
Bacillus thuringiensis var.
kurstaki or var. san diego

Nitrogen fixation genes and
antibiotic resistance genes
Nitrogen fixation genes and
antibiotic resistance genes
Nitrogen fixation genes and
antibiotic resistance genes
Nitrogen fixation genes and
antibiotic resistance genes
Nitrogen fixation genes and
antibiotic resistance genes
Delta endotoxin genes from
Bacillus thuringiensis var.
kurstaki or var. san diego

Nitrogen fixation genes and
antibiotic resistance genes
lac genes from
Escherichia coli

Introduced genetic material

Symbiotic nitrogen fixation
in alfalfa
Symbiotic nitrogen fixation
in alfalfa
Symbiotic nitrogen fixation
in alfalfa
Symbiotic nitrogen fixation
in soybeans
Symbiotic nitrogen fixation
in alfalfa
TMEs of pesticidal intermediates
of pesticides consisting
of encapsulated killed cells
for control of beetles
and caterpillar pests
TMEs of pesticidal intermediates
of pesticides consisting
of encapsulated killed cells
for control of beetles
and caterpillar pests
Symbiotic nitrogen fixation
in alfalfa

Symbiotic nitrogen fixation
in alfalfa
“Marker” genes for monitoring
the microorganism in the field

Purpose

Table 4.2 Agriculturally relevant genetically engineered microorganisms reviewed by EPA under TSCA under voluntary PMNs

84
C.A. Wozniak et al.

Research Seeds, Inc.

Research Seeds, Inc.

Research Seeds, Inc.

Univ. of Wisconsin, USEPA
Office of Research
& Development
Mycogen Corporation

1994

1994

1995

1995

1995

Research Seeds, Inc.

1993

One strain of Pseudomonas
fluorescens

Two strains of Rhizobium meliloti
(Sinorhizobium meliloti)

Five strains of Rhizobium meliloti
(Sinorhizobium meliloti)

Four strains of Bradyrhizobium
japonicum
Five strains of Rhizobium meliloti
(Sinorhizobium meliloti)

Five strains of Rhizobium meliloti
(Sinorhizobium meliloti)

Delta endotoxin genes from
Bacillus thuringiensis

Nitrogen fixation genes and
antibiotic resistance genes

Nitrogen fixation genes and
antibiotic resistance genes

Nitrogen fixation genes and
antibiotic resistance genes
Nitrogen fixation genes and
antibiotic resistance genes

Nitrogen fixation genes and
antibiotic resistance genes

TMEs of pesticidal intermediates
of pesticides consisting
of encapsulated killed cells for
control of lepidopteran pests

Symbiotic nitrogen fixation
in transgenic alfalfa

Test marketing large scale field
trials for one strain, RMBPC-2,
symbiotic nitrogen
fixation in alfalfa
Symbiotic nitrogen fixation
in soybeans
Additional test marketing field
trials for one strain, RMBPC-2,
symbiotic nitrogen
fixation in alfalfa
Additional test marketing field
trials for one strain,
RMBPC-2, symbiotic
nitrogen fixation in alfalfa
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Three strains of Bradyrhizobium japonicum
Three strains of Bradyrhizobium japonicum
Alcaligenes xylosoxidans subspecies
denitrificans strain AL6.1

Alcaligenes xylosoxidans subspecies
denitrificans strain AL6.1

Alcaligenes xylosoxidans subspecies
denitrificans strain AL6.1

1998
1999
2003

2004

2005

DsRed fluorescent protein marker gene

DsRed fluorescent protein marker gene

Nitrogen fixation and nodulation genes
Nitrogen fixation and nodulation genes
DsRed fluorescent protein marker gene

Nitrogen fixation in soybeans
Nitrogen fixation in soybeans
Detection in the environment – for eventual
insertion of pesticidal gene for control of
Xylella fastidiosa (Pierce’s disease of grapes)
Detection in the environment – for eventual
insertion of pesticidal gene for control of
Xylella fastidiosa (Pierce’s disease of grapes)
Detection in the environment – for eventual
insertion of pesticidal gene for control of
Xylella fastidiosa (Pierce’s disease of grapes)

Table 4.3 Agriculturally relevant genetically engineered microorganisms reviewed by EPA under TSCA under the biotechnology rule as TERAs
Fiscal year
Recipient microorganism
Introduced genetic material
Purpose
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Potential Future Applications

Biofertilizers
As previously mentioned, there are many biotechnology applications of genetically
engineered microorganisms that potentially may fall under the purview of TSCA
including a number of uses that are relevant to agriculture. These include intergeneric
microorganisms used as biofertilizers such as symbiotic nitrogen-fixers such as
Sinorhizobium meliloti and Bradyrhizobium japonicum. Field tests of numerous intergeneric rhizobia have gone through review under TSCA, and one particular strain of S.
meliloti, RMBPC-2, was approved in 1997 for limited commercialization. In the future,
there could be more submissions for more rhizobia for increased nitrogen-fixation ability, or perhaps, for enhanced nodulation efficiency. In addition, applications for other
symbiotic nitrogen fixers, such as the actinomycete Frankia which is a Gram positive
bacterium that forms symbiotic relationships with certain plants such as woody angiosperms referred to as actinorhizal plants, are a possibility. There may also be submissions for free-living nitrogen fixing microorganisms. In addition to nitrogen-fixing
intergeneric microorganisms, other biofertilizer applications that would be reviewed
under TSCA include phosphate-solubilizing microorganisms, mycorrhizal fungi, or
other endophytic microorganisms that aid in nutrient absorption, plant hormone production, or other mechanisms that may increase plant productivity.

Biosensors
Microbial biosensors consist of the use of a microorganism that has some sort of
reporter molecule that indicates the presence of a target molecule. The reporter genes
used in recombinant DNA technology for microbial biosensors include those that can
result in a signal that can be visible to the naked eye such as color production (e.g.,
blue color resulting from the breakdown of X-galactopyranoside by b-galactosidase),
bioluminescence (e.g., luc or lux genes), or fluorescence (e.g. gfp or DsRed). One of
the earliest genetically engineered microorganisms to be field tested was Monsanto’s
Pseudomonas chlororaphis (formerly P. aureofaciens) into which the b-galactosidase gene was inserted to enable detection of the microorganism in the environment.
The A. xylosoxidans reviewed under TSCA that was eventually to be manipulated
with pesticidal genes contained the DsRed protein for detection the microorganism
in the environment as well. Other biosensors with reporter genes for detection of
particular target molecules have been reviewed under TSCA as well. One such biosensor was a strain of Pseudomonas fluorescens Hk44 containing lux bioluminescence genes for detection of polycyclic aromatic hydrocarbons including naphthalene
and methyl salicylate. Another reporter biosensor was a strain of Pseudomonas
putida with genes for detection of unexploded ordinance, specifically trinitrotoluene
(TNT). Another biosensor microorganism, a P. putida containing lux genes was
reviewed that was developed for detection of trichloroethylene (TCE) and BTEX
compounds (benzene, toluene, ethylbenzene, and xylene). Other genetically engineered microbial biosensors have been developed for in situ detection of metals such
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as cadmium, nickel, cobalt, different forms of mercury, arsenite, and other heavy
metals such as copper, zinc, and lead (as summarized in Shin 2010).
Potentially, there could be a number of biosensor applications developed that
would be relevant to agriculture that would be subject to review under TSCA. Future
developments could include the use of intergeneric microorganisms as biosensors for
detection of bioterrorist agents, detection of other environmental pollutants, including
pesticides, some of which may have relevance to agriculture. Other potential agricultural
uses could be development of microbial biosensors for detection of pathogenic strains
of E. coli or Salmonella in the environment, for instance, in irrigation water, in soils,
in manures and other fertilizers that are used for food crop production. These types
of biosensors may be particularly useful for produce often consumed raw such as
lettuces, spinach, onions, etc. However, a biosensor such as this, if used to monitor
contamination on the actual food product rather than the environment in which the
crop is growing, would fall under the jurisdiction of the FDA rather than EPA. Other
agriculturally relevant future biosensors could be for monitoring nutrient or water
status of soils or contamination of water used in crop production or in aquaculture.
Pesticidal Intermediates
Pesticidal intermediates are an agricultural application reviewed under TSCA, and
several of these were reviewed in the 1980s. A pesticidal intermediate is a live
microorganism producing a pesticide that contains only inactivated microorganisms.
The final pesticide product containing dead microorganisms is reviewed by EPA’s
Office of Pesticide Programs under FIFRA. However, the live microorganism used in
the production of the pesticide is reviewed under TSCA as a pesticidal intermediate.
Future submissions of pesticidal intermediates may also be expected.
Weather Modification
Some of the earliest biotechnology applications involving intergeneric microorganisms involved those in weather modification. There was the ice-minus Pseudomonas
syringae for prevention of frost damage on strawberries. The commercial product
called Snomax is a strain of P. syringae that increases the nucleation temperature of
water, thereby increasing snow volume. Since strains of P. syringae are known plant
pathogens, USDA had the lead in reviewing these two products in the 1980s under
the Plant Protection Act. However, any such weather modification product produced
in the future using an intergeneric microorganism that did not fall under review by
another federal agency would be reviewed under TSCA.
Algal Biomass for Fuels and Other Uses Such as Animal Feeds, Aquaculture
Feed, Etc
Currently there are extensive R&D activities on using algae as a biofuel feedstock.
Characteristics of microalgae production that are advantageous include high biomass
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yields per acre, a lack of competition for arable land and sometimes nutrients, the
use of waste water, produced water, or saline water, the recycling of carbon through
use of CO2 from industrial flue gas or other sources, and because production is
compatible with an integrated biorefinery concept. Other aspects of microalgal culture
include rapid growth rate, high cell density, and high oil content. Algae may be able
to produce several fuel types including gaseous compounds like hydrogen and
methane, as well as a range of conventional liquid hydrocarbons. Most of the current
focus with algal biofuels is on the development of liquid transportation fuels including
gasoline, diesel, and jet fuel.
The U.S. Department of Energy biofuels roadmap (US DOE 2010) addressed
many aspects of this rapidly developing industry, including the variety of algal types,
methods to cultivate them, and processes to recover oil from them. Algae can be
grown photosynthetically using natural daylight or with artificial lighting. Heterotrophic
algae can be grown much like other industrial microorganisms via continuous culture
in the dark although when grown this way, they require a fixed carbon source such as
sugars. There are two primary cultivation approaches with many variations.
Photobioreactors utilize closed cycle recirculation systems employing either ambient
light or artificial illumination. Open pond production facilities are generally raceway
ponds of a recirculating design using pumps and paddle wheels to circulate water,
algae, and nutrients through shallow open ponds. Hybrid systems growing algae in the
environment may also be used, however perhaps with enclosures such as plastic bags,
to contain the algae rather than growing them in the open.
Commercial fuel production from algae is in its infancy, but the growth of algae
for commercial production of high-value end products such as pharmaceuticals and
“nutraceuticals” has existed for some time. Products such as carotenoids, phycobilins, fatty acids, polysaccharides, vitamins, sterols, and biologically active molecules for use in human and animal health are produced by algae commercially
(Oilgae 2010). Any intergeneric algae used for biofuel production would be reviewed
under TSCA. Although these high-value end products other than fuels mentioned
above would be reviewed by other federal agencies, TSCA would be involved if the
algae were also producing biofuels.

4.7

Conclusions

Regulation of genetically engineered microbial agents, whether for pest management purposes or environmental bioremediation, has afforded the proper oversight
of a novel technology as part of a larger attempt to reduce the uncertainty of the risk
assessment process. With the advent of a new technology, uncertainties and lack of
a proven track record necessitate thorough review of these microbes to ensure
human health and environmental safety (Harrison and Bonning 2000). While the
addition of a transgene to a familiar microbial genome may alter the phenotype of
the microbe, these microbes are guided by the same biochemical and genetic processes
as naturally occurring microbes (NRC 2000). Hence, they were assessed with that
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fact in mind, albeit under an initial higher level of scrutiny and oversight. As indicated
by Wrubel et al. (1997), decisions regarding further research and development of
GE MPCA products may have been considerably influenced by unknowns in
regulatory oversight, however, in the majority of cases an inability of the proposed
product to live up to expectations was the driving force behind a products demise.
One must not discount the perceived influence of public acceptance and its relationship
to marketing of products, particularly when they involve food and feed.
Reports from the early field experiments with GE bacteria reveal how controversial and polarizing these first ventures were in the public arena (Griffin 1988; Berg
and Singer 1995). Today this is largely not the case, although many have learned
the value in public education and involvement in field testing novel technologies.
It is still possible, however, to emote fear of the unknown without really intending
to (Dixon 2008).
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